Clinical Control Trial of Methylprednisolone and Dexamethasone in Treatment of Intracranial Tumor Edema

Journal of Sichuan University (Medical Science)

Volumn 34, Issue 2, 2003, Pages 327-329

  Ding, Xinmin ^a   Mao, Boyong ^a   Ju, Yan ^a   Liu, Yanhui ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Dexamethasone; Methylprednisolone; Peritumoredema

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CORTICOSTEROID; DEXAMETHASONE; METHYLPREDNISOLONE;

ARTICLE; BRAIN EDEMA; BRAIN TUMOR; CELLULAR IMMUNITY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; HUMAN; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT OUTCOME;

EID: 0242643428     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Bracken MB, Shepard MJ, Holford TR, et al. Adminisration of methylprednisolone for 24 or 48 hors or tirilazasdmesylate for 48 ours in the treatment of acute spinal cord injury: Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. JAMA, 1997; 277(20): 1597
2. Ohnishi T, Sher PB, Posner JB, et al. Capillavy permeability factor secreatd by malignant brain tumor. J Neurosury, 1990; 72(2): 245
3. Anderson C, Jensen FT. Ditferances in blood-tumor-bawier leage of human intra cranial tumors: quantative monitoring of vaso genic edema and itd response to glu co corticoid treatment. Acta Neurochir Wien, 1998; 140 (9): 919
4. Skjoeth J, Effect of glucorti coids on ICP in patients with a cerebral tumor. Acta Neuro Scand, 1997; 96 (3): 167
5. Horakova L, Ondrejickova O, Bachrata K, et al. Preventive effect of several antioxidants after oxidative stress on rat brain homogenates. Gen Physiol Biophys, 2000; 19(2): 195